Toxoplasma gondii infection and ABO blood groups: a systematic review and meta-analysis

被引：1
作者：
Nayeri, Tooran [1 ]
Moosazadeh, Mahmood [2 ]
Asl, Abdolhossein Dalimi
Ghaffarifar, Fatemeh [3 ]
Sarvi, Shahabeddin [1 ,4 ]
Daryani, Ahmad [1 ,4 ]
机构：
[1] Mazandaran Univ Med Sci, Sch Med, Dept Parasitol, Sari 4816895475, Iran
[2] Mazandaran Univ Med Sci, Noncommunicable Dis Inst, Gastrointestit Canc Res Ctr, Sari 4816895475, Iran
[3] Tarbiat Modares Univ, Fac Med Sci, Dept Parasitol & Entomol, Tehran 14115331, Iran
[4] Mazandaran Univ Med Sci, Communicable Dis Inst, Toxoplasmosis Res Ctr, Sari 4816895475, Iran
来源：
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2024年 / 118卷 / 04期
关键词：
ABO; blood donors; blood groups; Toxoplasma gondii; toxoplasmosis; RISK-FACTORS; PARASITIC INFECTIONS; PREGNANT-WOMEN; SEROPREVALENCE; ANTIBODIES; DONORS; ASSOCIATION; PHENOTYPE; EAST;
D O I：
10.1093/trstmh/trad085
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The current study aimed to determine the prevalence of Toxoplasma gondii in ABO blood groups and assess the relationship between the prevalence of T. gondii and blood groups. A literature search was carried out for epidemiological studies that were published through December 2022. A random effects model was used to determine the OR and the pooled prevalence with a 95% CI. The estimated pooled prevalences of T. gondii infection in the A, B, AB and O blood groups were 38% (95% CI 27 to 48%), 38% (95% CI 29 to 47%), 36% (95% CI 26 to 45%) and 36% (95% CI 27 to 45%), respectively. Also, the pooled ORs of the relationship between the prevalence of T. gondii infection and the A, B, AB and O blood groups were 1.08 (95% CI 0.97 to 1.19), 1.10 (95% CI 0.95 to 1.28), 1.08 (95% CI 0.92 to 1.27) and 0.89 (95% CI 0.80 to 1.00), respectively. This meta-analysis did not show any relationship between the prevalence of T. gondii infection and ABO blood groups.
引用
收藏
页码：234 / 246
页数：13
相关论文
共 65 条
[1]  
Abdulla C., 2022, HIV Nurs., V22, P2713
[2]  
Aboud RA., 2017, DJM, V12, P84
[3]  
Al-Masoudi HK., 2018, J PHARM SCI RES, V10, P2391
[4]  
Al-Tufaili RAN., 2020, SYSTEMATIC REV PHARM, V11, P57, DOI DOI 10.31838/SRP.2020.12.10
[5]  
Alawaini KA., 2021, WORLD J ADV RES REV, V10, P169
[6]   Parasitic infections in transplant recipients [J].
Barsoum, Rashad S. .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (09) :490-503
[7]  
Barzinij Abdul Kadir R. A., 2021, Annals of Parasitology, V67, P175, DOI 10.17420/ap6702.327
[8]  
Belkacemi M., 2022, CUREUS J MED SCIENCE
[9]   Pathogenesis of toxoplasmosis [J].
Bhopale, GM .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2003, 26 (04) :213-222
[10]  
de Mattos CCB, 2008, ARCH MED SCI, V4, P254
1234567